Abstract

BACKGROUND

Young female adult and adolescent cancer patients facing life-preserving but fertility-threatening chemo- or radiation-therapy are increasingly seeking options to protect their reproductive potential. Ovarian tissue cryopreservation with transplantation is a promising technique to safeguard fertility in cancer patients. However, this method may risk re-introduction of the original cancer to the survivor of the disease. Thus, developing a method for in vitro growth of immature follicles may provide a method for fertility restoration in the future.

METHODS

Human secondary follicles were isolated from ovarian tissues obtained from cancer patients and grown in vitro within a bio-engineered culture system for 30 days.

RESULTS

Human ovarian follicles became steroidogenically active, and developed from the early secondary to antral stage in vitro. The follicles contained healthy, growing oocytes that were connected by transzonal projections between the somatic cells and oocyte.

CONCLUSIONS

Our data support the notion that human follicle development can be achieved in vitro in a bio-engineered culture system. More studies are required to investigate whether the fully sized oocytes obtained from in vitro grown follicle are competent to resume meiosis and be fertilized.

Introduction

Young women facing a new cancer diagnosis are left with difficult choices, not only in how to manage their cancer, but also to decide whether to take fertility-protective measures. Several chemotherapeutics used in anti-cancer regimens unintentionally threaten fertility by destroying the immature follicle pool. The elimination of the primordial follicle pool results in either acute ovarian failure or a chronic ovarian insufficiency, resulting in an early menopause and associated loss of reproductive capacity (Agarwal and Chang, 2007; Cvancarova et al., 2009; Jeruss and Woodruff, 2009; Schover, 2009). For female adolescents and young adults, the increasing probability of surviving a cancer diagnosis combined with the expectation and desire for reproductive options following cancer remission is driving the intense need for fertility sparing techniques.

Currently, there are several methods available to women hoping to preserve their fertility before cancer therapy. As it has been used most often, traditional hormone stimulation and in vitro fertilization (IVF) followed by embryo cryopreservation is the most successful approach to preserve fertility (Oktay et al., 2003, 2005; Rao et al., 2004; Juretzka et al., 2005; Lee et al., 2006). Recently, live births have also been achieved with cryopreserved oocytes harvested before cancer treatment (Yang et al., 2007; Porcu et al., 2008). However, both methods require a delay in cancer treatment and hormonal stimulation that are not prudent for some patients. In contrast, ovarian tissue cryopreservation followed by transplant is a promising fertility preservation approach that can usually be performed immediately without hormonal stimulation. Transplantation of ovarian cortical strips has resulted in viable offspring in sheep (from cryopreserved tissue) (Gosden et al., 1994; Salle et al., 2002) and monkeys (from fresh tissue) (Lee et al., 2004). In the human, ovarian function can be restored within 3 months after transplanting thawed tissue into a woman with ovarian failure (Oktay et al., 2004; Schmidt et al., 2005; Demeestere et al., 2006; Rosendahl et al., 2006). Furthermore, live births in humans have been achieved by transplanting fresh ovarian tissue (Silber et al., 2005, 2008; Silber and Gosden, 2007). Worldwide, five live births have been reported thus far as a result of auto-transplanting frozen/thawed ovarian tissues (Donnez et al., 2004; Meirow et al., 2005; Demeestere et al., 2007; Andersen et al., 2008). Despite these promising findings, transplantation of cryopreserved tissue carries the risk of re-introducing cancer cells into the patient (Shaw and Trounson, 1997; Meirow et al., 1998, 2008). Thus, the in vitro growth of immature follicles derived from ovaries collected prior to commencement of cancer treatment is an important direction for research.

Phenocopying the complex interplay of growth factors and hormone signals required for the coordinated developmental process of follicle development and oocyte maturation in vitro is challenging; yet follicle culture systems for mouse (Eppig and Schroeder, 1989; Spears et al., 1994; Cortvrindt et al., 1996; Eppig and O'Brien, 1996; O'Brien et al., 2003; Xu et al., 2006a, b), large animals (Newton et al., 1999; Gutierrez et al., 2000; Telfer et al., 2000; Wu et al., 2001; Picton et al., 2003; Thomas et al., 2007) and the human (Roy and Treacy, 1993; Abir et al., 1997, 1999, 2001, 2006; Hovatta et al., 1997; Wright et al., 1999; Scott et al., 2004a, b; Telfer et al., 2008, Amorim et al., 2009) have been developed in both 2-dimensional (2D) and 3-dimensional (3D) formats. These systems have been successful in supporting the development of mouse secondary follicles, but have not yet been adapted for routine use in large animals and the human. The purpose of the in vitro human follicle growth (IVFG) system is to mimic the in vivo process by providing follicles with appropriate growth factors and hormones, in the correct amount, at the right time, which allows growth of the follicle and oocyte whereas maintaining the essential connections between somatic cells and the oocyte called transzonal projections (TZPs) (Anderson and Albertini, 1976; Albertini and Barrett, 2003).

The aim of the present study was to investigate in vitro human secondary follicle growth and survival in a long-term 3D culture system. We examined the ability of these follicles to form an antrum, secrete hormones and support oocyte development.

Materials and Methods

Ovary collection

Ovarian tissues were obtained from 14 female cancer patients (Table I), ages 16–39 years (mean ± SD, 27.3 ± 8.1) following informed consent under an Institutional Review Board-approved protocol at Northwestern University. These patients were seeking fertility-sparing options in our Oncofertility program, which provided them with a full-range of fertility-sparing options. Ovaries were removed by laparoscopic and transported to the laboratory in <2 h in cold (4°C) MOPS-HTF Medium (CooperSurgical, Trumbull, CT, USA).

Table I

Secondary follicle isolation

Patient Age Diagnosis FL-Mgel (nFL-ALG (nTotal (n
Pt1 36 Breast Cancer 
Pt2 39 Breast Cancer 
Pt3* 36 Breast Cancer 0* 
Pt4* 36 Breast Cancer 0* 
Pt5 29 Cervical Cancer 
Pt6 19 Ewing's Sarcoma 
Pt7* 16 Ewing's Sarcoma 0* 
Pt8* 26 Hodgkins Lymphoma 5* 
Pt9 16 Non-Hodgkins Lymphoma 
Pt10 33 Ovarian Cancer 
Pt11 27 Ovarian Mass 
Pt12 27 Ovarian Mass 
Pt13 16 Penioblastoma 
Pt14 26 Rectal Cancer 
Patient Age Diagnosis FL-Mgel (nFL-ALG (nTotal (n
Pt1 36 Breast Cancer 
Pt2 39 Breast Cancer 
Pt3* 36 Breast Cancer 0* 
Pt4* 36 Breast Cancer 0* 
Pt5 29 Cervical Cancer 
Pt6 19 Ewing's Sarcoma 
Pt7* 16 Ewing's Sarcoma 0* 
Pt8* 26 Hodgkins Lymphoma 5* 
Pt9 16 Non-Hodgkins Lymphoma 
Pt10 33 Ovarian Cancer 
Pt11 27 Ovarian Mass 
Pt12 27 Ovarian Mass 
Pt13 16 Penioblastoma 
Pt14 26 Rectal Cancer 

Note: FL-Mgel, follicle cultured in Matrigel; FL-ALG, follicle cultured in 0.5% alginate.

*The patients received chemo/radiations therapy before tissue donation.

Follicle isolation

All follicles included in this study were isolated from fresh tissue using a modified method as described previously (Abir et al., 1999). Briefly, ovarian cortical strips were cut into ∼1 mm3 pieces in dissection media (Liebovitz L-15 media, Invitrogen, Carlsbad, CA, USA) supplemented with 1% Serum Protein Substitute (SPS, CooperSurgical, Trumbull, CT, USA), 100 IU/ml penicillin and 100 mg/ml streptomycin (Invitrogen, Carlsbad, CA, USA). The tissue was then enzymatically digested by transferring to incubation media, made by supplementing dissection media (above) with 0.2% collagenase and 0.02% DNase (Worthington Biochemical, Lakewood, NJ, USA), for 1.5 h at 37°C in a shaking water bath. In most cases, this short-term digestion was not enough to completely free follicles from the ovarian cortex because of the toughness of human cortex; however, the enzymatic digestion facilitated the following mechanical isolation. After rinsing cortex twice with fresh dissecting media, follicles were then mechanically isolated from the cortex using 25-gauge needles in dissection media, transferred to maintenance media (αMEM, (Invitrogen, Carlsbad, CA, ISA), supplemented with 1% SPS, 100 IU/ml penicillin and 100 µg/ml streptomycin), and placed in an incubator at 37°C and 5% CO2. The mechanical isolation was carried out for 2–6 h prior to encapsulation. Only immature follicles (Class 1 and 2) (Gougeon, 1996) that contained a clear, visible, centrally-located oocyte, healthy granulosa cells and no signs of antrum formation were encapsulated and cultured (Fig. 1A). A few small antral follicles were fixed in 4% paraformaldehyde (PFA) as a control for confocal analysis of follicle structure, oocyte-somatic cell interactions as well as germinal vesicle (GV) stage.

Figure 1

Characteristics of in vitro growth follicles.

Figure 1

Characteristics of in vitro growth follicles.

Matrix preparation

Sodium alginate (55–65% guluronic acid) was obtained from FMC BioPolymers (Philadelphia, PA, USA). A 1% (w/v) solution of sodium alginate was stripped using activated charcoal (0.5 g charcoal/g alginate) to remove organic impurities, sterile filtered using 0.22 µm filters, and lyophilized within Steriflip conical tubes (Millipore, Billerica, MA, USA). Sodium alginate was reconstituted to 0.5% (w/v) alginate in 1× phosphate buffered saline (PBS) for use (Xu et al., 2006a, b). Matrigel (BD Cat 354234, Bedford, MA, USA) was thawed on ice overnight, and diluted 1:3 with cold αMEM (Scott et al., 2004a, b).

Follicle encapsulation and culture

Selected follicles were encapsulated into either a 0.5% alginate bead (Xu et al., 2006a, b) or embedded into diluted Matrigel matrix as previously described (Scott et al., 2004a, b) with slight modification. Briefly, single follicles were transferred to individual droplets of alginate (∼5 µl) on a polypropylene mesh (0.1 mm opening, McMaster-Carr, Atlanta, GA, USA). The mesh was then inverted and gently tapped over a cross-linking solution (50 mM CaCl2 and 140 mM NaCl), causing the droplets to fall into the solution (Xu, et al., 2009). The beads were allowed to cross-link for two minutes, removed, and rinsed in maintenance media. Beads were then transferred to individual wells of a 96-well plate containing 100 µl of culture media (Xu et al., 2006a, b) [αMEM supplemented with 6% SPS (v/v), 1 mg/ml bovine fetuin (Sigma-Aldrich, St. Louis, MO, USA), 5 µg/ml insulin, 5 µg/ml transferrin, 5 ng/ml sodium selenite (Sigma-Aldrich, St. Louis, MO, USA) and 0.1 IU/ml FSH (gift from Organon, Roseland, NJ, USA)]. SPS was used here to replace the bovine serum albumin used for murine follicle culture. To embed a follicle into the Matrigel, the Millicell insert (Millipore, Billerica, MA, USA) was filled with 100 µl diluted Matrigel and permitted to pre-gel for 30 min. The individual follicle was then transferred into the middle of the Matrigel and allowed to gel in the incubator for an additional 30 min. The insert was then transferred to one well of a 24-well plate containing 400 µl of the culture media described above. Follicles, either encapsulated within 0.5% alginate or embedded within Matrigel were cultured at 37°C with 5% CO2 for up to 30 days. At different time points, some follicles were fixed or frozen for histological examination or gene expression analysis (unpublished data). Ten follicles from each treatment group were grown for 30 days. Every 2 days, half of the culture media was exchanged and stored at −80°C for hormonal measurements. Fresh culture media was prepared weekly.

Follicle and oocyte measurement

Photographs of each follicle (during the culture period) were captured using a Leica DM IL light microscope (Leica, Wetzlar, Germany) equipped with phase objectives, a heated stage, a Spot Insight 2 Megapixel Color Mosaic camera and Spot software (Spot Diagnostic Instruments, Sterling Heights, MI, USA). Follicle diameters were later measured using ImageJ software (National Institutes of Health, USA) as previously described (West et al., 2007; West-Farrell et al., 2009). Oocyte diameters were measured without zona pellucida.

Sectioning and staining

Follicles were fixed in 4% PFA for 30 min at 37°C and then overnight at 4°C. Fixed follicles were dehydrated in increasing concentrations of ethanol (10–100%) and embedded in paraffin using an automated tissue processor (Leica, Manheim, Germany). Serial 5 µm sections were cut and stained with hematoxylin and eosin.

3D confocal staining and imaging

Follicles for confocal microscopy studies were fixed in 4% PFA at 37°C for 1 h, followed by 1 h in wash buffer (Barrett and Albertini, 2007). They were then stained overnight at 4°C on a shaker with Rhodamine-Phalloidin (1:50 Molecular Probes, Invitrogen, Eugene, Oregon) that labels F-actin in TZPs, rabbit anti-connexin 43 (1:100 Zymed) that labels gap junctions or affinity purified polyclonal rabbit antisera that recognize the inhibin βA-subunit (1:100) or the inhibin βB-subunit (1:100). The inhibin subunit antisera were a gift from Dr W. Vale (The Salk Institute, La Jolla, CA, USA). The primary antibodies were followed by incubation with 1:800 goat anti-rabbit Alexa 568 for inhibin βA and connexin 43, 1:800 goat anti-rabbit Alexa 488 for inhibin βB (Molecular Probes) and 1 µg/ml Hoechst 33342 (Molecular Probes) for chromatin/DNA. Follicles were mounted in 5–10 µl of a 50% glycerol/PBS solution containing 25 µg/ml sodium azide. The coverglass was placed on glass shards, to prevent the compression of the follicle. Follicles were imaged on a Zeiss LSM 510 confocal microscope using a Neoflaur 40× oil objective. Overlapping 1–3 µm sections were taken throughout each follicle imaged.

Hormone assays

17β-estradiol (E2) and Progesterone (P4) concentrations in culture media were measured by specific electrochemiluminescent assay using a Roche Elecsys 2010 Analyzer (Roche, Indianapolis, IN, USA). The inter-assay variations were 6.1% for 17β-estradiol and 5.4% for progesterone. The limits of sensitivity were 5 pg/ml for 17β-estradiol and 0.03 ng/ml for progesterone. Inhibin A, inhibin B and anti-Müllerian hormone (AMH) were measured using ELISA kits (DSL-10-28100, DSL-10-84100 and DSL-10-14400, Diagnostic Systems Laboratories, Webster, TX, USA) following manufacturer instructions. The intra-assay variations were 8.7% for inhibin A, 3.2% for inhibin B and 3.8% for AMH. The limits of sensitivity for inhibin A, inhibin B and AMH were 10, 10 and 20 pg/ml, respectively.

Results

Isolation and growth of human secondary follicles

In order to assess the ability of human secondary follicles to grow in 3D matrices, we isolated follicles from ovarian tissues donated from 14 different Oncofertility patients (Table I). The number of secondary follicles isolated, from each patient sample ranged from 0 to 9, which varied based on tissue amount, patient age, cancer type and whether the patient received prior chemo/radiation therapy.

Follicles were cultured for up to 30 days by embedding in matrigel (n = 18) or encapsulation in alginate (n = 22). The average size of un-cultured isolated follicle was similar between culture groups, matrigel = 170.8 µm (±51.1) and alginate = 178.4 µm (±69.2). Matrigel embedded secondary follicles (Fig. 1A) or alginate encapsulated follicles (Fig. 1A inset) displayed at least two cell layers of granulosa cells. After 5 days of culture both groups of follicles displayed theca-like cells surrounding the follicle basement membrane (Fig. 1B). By day 15 of culture, follicles observed by brightfield microscopy contained a fluid filled antrum and distinct mural granulosa and cumulus granulosa cell types (Fig. 1C). The follicle also displayed a thickening of the theca-like cell layer. By day 30 of culture, the cumulus-oocyte complex was barely detectable by light microscopy due to the size of the follicle (Fig. 1D).

Because both matrigel and alginate environments supported follicle growth without significant differences (data not shown), the growth data were combined (Fig. 2). From day 0 to day 30 follicles linearly grew in size from 175 ± 10 to 715 ± 68 µm. Moreover, the oocyte size also increased in culture as the follicle grew three-dimensionally. After day 15 of culture, the oocyte could no longer be observed for measurement until the follicle was fixed for analysis. All secondary follicles that were grown for 30 days survived through the culture, and 75% of follicles developed visible antrum that commenced on approximately day 12 (±3.9) of culture in follicles with an average diameter of 393.6 µm (±93.6).

Figure 2

In vitro follicle and oocyte growth.

Figure 2

In vitro follicle and oocyte growth.

In vitro grown follicles secrete steroid and peptide hormones

To determine whether IVFG was similar to in vivo follicles in their capacity to secrete hormones, we analyzed growth media from individual follicles every other day of culture. Steroid hormones were not detected in the condition media before day 5. Increasing levels of steroid hormones, 17β-estradiol and progesterone, were measured in conditioned media collected from individual follicle cultures on day 5 through day 30 (Fig. 3A and B). The ratio of 17β-estradiol to progesterone decreased over the culture period (Fig. 3C). The peptide hormone inhibin A continually increased as follicles were cultured to 30 days whereas inhibin B increased from day 4 to day 16 but decreased from day 16 to day 30. AMH was also measured in cultured follicles and followed the secretion of inhibin B (Fig. 3). When comparing all hormones (Fig. 4A) over time in one single follicle (seen in Fig. 1), it was found that secondary follicles grown in vitro did not secrete steroid nor peptide hormones at detectable levels during the initial days of culture (days 0–4), however, all hormones were measurable by day 8. All hormones examined appeared to increase steadily until day 20 of culture after which levels of AMH began to drop slowly and inhibin B decreased rapidly. Both inhibin β-subunits (βA and βB) were localized to the mural granulosa cells of the same follicle at 30-days of culture (Fig. 4B and C).

Figure 3

Hormone levels in human follicle cultures.

Figure 3

Hormone levels in human follicle cultures.

Figure 4

Steroid and peptide hormone profile in a growing secondary follicle.

Figure 4

Steroid and peptide hormone profile in a growing secondary follicle.

In vitro follicle growth supports oocyte growth

Since the connection between somatic cells and the oocyte has never before been studied in human follicles, we used confocal reconstructions to observe the F-actin based connections (TZPs) in freshly isolated, early-antral follicles (Fig. 5A). We examined 14-day cultured follicles for the presence of TZPs and found that they maintain a dense network of TZPs emanating from the surrounding granulosa cells (Fig. 5B). We also reconstructed these cultured follicles and found them to be similar to the in vivo benchmark follicles (http://oncofertility.northwestern.edu/research/human-follicle-maturation-in-vitro/shared-files). This follicle also showed the formation of an early antrum and the differentiation of a mural granulosa and cumulus granulosa. Connexin 43, a gap junction protein, was also examined in cultured follicles and was shown to be present at the cumulus granulosa cell junctions (Fig. 5C). Oocyte growth increased with time in culture from 75 µm to a terminal size of 110 µm (Fig. 2). This size was indistinguishable from competent oocytes aspirated from in vivo antral human follicles that went on to mature to MII stage in culture (Fig. 2). Healthy and intact GVs were seen during early stages of culture. Stage II GVs were observed in both fresh-isolated follicles (Fig. 5A, inset) as well as cultured follicles (14 days) (Fig. 5B inset) and progressed to stage IV by the end of culture (Fig. 5D).

Figure 5

In vitro growth follicles resemble in vivo follicles.

Figure 5

In vitro growth follicles resemble in vivo follicles.

Discussion

In vitro follicle growth provides the opportunity to expand research initiatives in follicle development, as well as to potentially provide expanded options to young cancer patients. Various groups (Abir et al., 1997; Hovatta et al., 1997; Wright et al., 1999; Telfer et al., 2008), including our own are working toward robust, reliable in vitro systems that will provide the next generation of research discoveries as well as 1 day aiding in fertility sparing plans for cancer patients. To achieve these two goals, we have adapted two 3D systems to human follicles. To the best of our knowledge, this is the first report in the humans showing the in vitro growth of large, antral follicles, which contains full size oocytes with stage IV GVs, from secondary stage in vitro. Importantly, the systems reported here can be further engineered to continue improving the in vitro environment in which these follicles grow. We suspect that the combination of engineered ECM (Kreeger et al., 2006; Xu et al., 2007), rigidity (Xu et al., 2006a, b; West et al., 2007) and the ability to temporally provide hormones (Kreeger et al., 2005) to individual follicles will create the next generation of improvement in a system that has already demonstrated significant success in the murine model.

Follicle growth

Previous studies have shown human follicle development in vitro (Roy and Treacy, 1993; Abir et al., 1997; Telfer et al., 2008). Antrum formation was previously achieved using cultured secondary follicles (Roy and Treacy, 1993; Abir et al., 1997); this development was shown to be dependent on FSH (Abir et al., 1997). Theca-like cells were observed when unilaminar follicles developed to secondary follicles in a collagen gel culture system (Abir et al., 1999, 2001). More recently, primordial/primary follicles were shown to enter the growing pool of follicles and develop to early antral stage (∼150 µm) in 10 days using a two-step serum-free culture system in the presence of activin A (Telfer et al., 2008). In another study, primordial/primary follicles (34–51 µm) isolated from cryopreserved tissue survived for 7 days and increased in size up to 44–70 µm in alginate matrix culture system (Amorim et al., 2009). We used 3D culture systems to culture small secondary follicles (Class 1 and 2 as described by Gougeon, 1996). In our study, individual non-antral, secondary follicle grew substantially over 30 days, and reached an average size of 800 µm. Our studies have also shown that 30 days of culture was enough time to grow follicles to 1 mm and produce oocytes with nuclear competence (stage IV GVs). The growth of the oocyte correlated with an increase in follicle size; the fact that oocyte growth and development was supported in conjunction with follicle growth was a significant achievement. Though we have not yet explored whether these oocytes also have cytoplasmic competence after 30 days in culture, it has been shown that a follicle size of 1.6 mm can be aspirated for cumulus-oocyte complexes and matured in vitro (Chian et al., 2004), therefore 30 days of IVFG may be enough time for the secondary follicle to reach this step.

The final expansion of the follicle is largely attributed to the size of the antrum, which is associated with a prodigious increase in hormones (principally estrogen) necessary to drive an ovulatory signal (LH) from the pituitary gland. Moreover, the follicle must grow outward from the perimedullary zone to permit contact between the follicle surface and the ovarian surface in anticipation of ovulation. In vitro systems do not have to phenocopy the properties of the follicle that relate to maintaining a menstrual cycle and extruding an oocyte—they simply have to accommodate the oocyte to the point where nuclear and cytoplasmic maturation can occur. Thus, our goal for the human follicle growth project is not to generate a 20 mm follicle, rather, to determine what length of culture and what antrum size is necessary to produce an oocyte competent to resume meiosis in vitro. Based on the data presented here, our culture conditions support follicle growth to an appropriate in vitro terminal size.

Hormones

We next investigated whether the human ovarian follicles grown in vitro were hormonally active. The pattern of hormone secretion from the growing human follicles was similar to the pattern observed during the human menstrual cycle (Welt et al., 1999; Klein et al., 2004). The earliest detectable hormone released (above baseline) from the follicle was AMH. AMH secretion was followed by estradiol and the inhibins. Inhibin A and 17β-estradiol were positively correlated throughout follicle development, although inhibin B levels fell as the follicles achieve ‘dominant’ status. Average AMH decreased as the inhibin A increased and inhibin B fell (Fig. 3). AMH remains elevated in the individual follicle depicted in Fig. 4. Understanding the relationship between AMH and follicle/oocyte maturity is a future goal of this work. Baseline levels of progesterone from newly isolated follicles were unexpectedly higher than one might predict, however, progesterone levels have never been measured in a secondary human follicle. The effects of the progesterone on follicle development were unknown, but did not impact follicle growth or oocyte development. Like the other hormones, progesterone secretion was maintained at basal level for the first week of culture and did not increase until estrogen and the peptide hormones levels rose. Importantly, the ratio of estradiol to progesterone was consistent during the last 2 weeks culture after the antrum has formed, which indicated no significant luteinization has occurred in the cultured follicle. We can confirm the relative health of granulosa cells by observing the low cytoplasm to nucleus ratio in the confocal images of freshly isolated and in vitro cultured follicles. Moreover, the inhibin βB subunit was known to be expressed in healthy granulosa cells and not in luteinized human tissue (Groome et al., 1996; Klein et al., 2004). Thus, the ovarian follicles grown in vitro were capable of sustained hormone production, which phenocopied the patterns of the hormones secreted by follicles in vivo.

Oocyte status

In addition to overall follicle size and growth patterns, the development and maturation of the oocytes described here mirrors that of in vivo matured follicles, or freshly isolated in vitro matured follicles. The key anatomical structures that provide communication routes between the somatic cells and the oocyte are the TZPs (Albertini and Barrett, 2003). Although these actin-based cytoplasmic processes are known to be present in mature human cumulus-oocyte complexes, their existence in immature human follicles, although expected, has not previously been established. We isolated fresh, immature human follicles that were fixed, and then imaged by confocal microscopy. Importantly, we found that cultured immature human follicles did indeed maintain a dense network of TZPs. Because we were able to maintain these structures with our 3D matrices, oocyte growth increased with time in culture from 75 µm to a terminal size of 110 µm. This size was indistinguishable from meiotically competent oocytes aspirated from small antral human follicles in vivo (Cavilla et al., 2008). During the early stages of culture, freshly isolated follicles and cultured follicles (14 days) had displayed healthy, appropriately staged, intact GVs (nucleoli stage II), which progressed to stage IV by the end of culture. It was documented that oocytes with GV stage IV developed nuclear competence and that, depending on cytoplasmic competence, these oocytes should be able to resume meiosis in preparation for fertilization (Combelles et al., 2002). Thus, the in vitro 3D culture system supported coordinated follicle and oocyte growth creating an environment in which the major steps of human follicle development were maintained.

Our studies revealed that early secondary follicles, once removed from the restricted environment of the ovary, had the capability of surviving and growing in culture. By using a 3D supportive matrix, follicles were able to maintain bidirectional communication between somatic cells and the germ cell creating an environment conducive for oocyte growth and proper steroid production. The next frontier will be maturation of in vitro grown oocytes to MII, fertilization and embryo development, and the adaption of these techniques to primordial follicles and cryopreserved tissues.

Author's Role

M.X. design, acquisition of data, analysis, interpretation. S.L.B. acquisition of data, interpretation and critical review. E.W.-F., L.A.K. and S.E.K. acquisition of data, analysis. L.D.S. interpretation, critical review. T.K.W. design, interpretation, critical review, final approval.

Supplementary data

Supplementary data are available at http://humrep.oxfordjournals.org/.

Funding

This research was supported by grants from the National Institutes of Health to the Oncofertility Consortium, grant numbers: NIH RL1HD058295 and PL1EB008542. The content is solely the responsibilities of the authors and does not necessarily reflect the official views of the National Institutes of Health.

Acknowledgements

The authors thank Jill Trainer and Jen Jozefik for their assistance in the preparation of this manuscript; Tyler Wellington and the Northwestern University Reproductive Science Histology Core for tissue processing and sectioning; and members of the Oncofertility Consortium for helpful discussions including: Steve Rosen, M.D., Jacqueline Jeruss, M.D., Ph.D., Richard Stouffer, Ph.D., Mary Zelinski, Ph.D., Jeff Chang, M.D., Christos Coutifaris, M.D., Ph.D. Marybeth Gerrity, Ph.D. and Bob Brannigan, M.D.

References

Abir
R
Franks
S
Mobberley
MA
Moore
PA
Margara
RA
Winston
RM
Mechanical isolation and in vitro growth of preantral and small antral human follicles
Fertil steril
 , 
1997
, vol. 
68
 (pg. 
682
-
688
)
Abir
R
Roizman
P
Fisch
B
Nitke
S
Okon
E
Orvieto
R
Ben Rafael
Z
Pilot study of isolated early human follicles cultured in collagen gels for 24 hours
Hum Reprod
 , 
1999
, vol. 
14
 (pg. 
1299
-
1301
)
Abir
R
Fisch
B
Nitke
S
Okon
E
Raz
A
Ben Rafael
Z
Morphological study of fully and partially isolated early human follicles
Fertil Steril
 , 
2001
, vol. 
75
 (pg. 
141
-
146
)
Abir
R
Nitke
S
Ben-Haroush
A
Fisch
B
In vitro maturation of human primordial ovarian follicles: clinical significance, progress in mammals, and methods for growth evaluation
Histol Histopathol
 , 
2006
, vol. 
21
 (pg. 
887
-
898
)
Agarwal
SK
Chang
RJ
Fertility management for women with cancer
Cancer Treat Res
 , 
2007
, vol. 
138
 (pg. 
15
-
27
)
Albertini
DF
Barrett
SL
Oocyte-somatic cell communication
Reprod Suppl
 , 
2003
, vol. 
61
 (pg. 
49
-
54
)
Amorim
CA
Van Langendonckt
A
David
A
Dolmans
MM
Donnez
J
Survival of human pre-antral follicles after cryopreservation of ovarian tissue, follicular isolation and in vitro culture in a calcium alginate matrix
Hum Reprod
 , 
2009
, vol. 
24
 (pg. 
92
-
99
)
Anderson
E
Albertini
DF
Gap junctions between the oocyte and companion follicle cells in the mammalian ovary
J Cell Biol
 , 
1976
, vol. 
71
 (pg. 
680
-
686
)
Andersen
CY
Rosendahl
M
Byskov
AG
Loft
A
Ottosen
C
Dueholm
M
Schmidt
KL
Andersen
AN
Ernst
E
Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue
Hum Reprod
 , 
2008
, vol. 
23
 (pg. 
2266
-
2272
)
Barrett
SL
Albertini
DF
Allocation of gamma-tubulin between oocyte cortex and meiotic spindle influences asymmetric cytokinesis in the mouse oocyte
Biol Reprod
 , 
2007
, vol. 
76
 (pg. 
949
-
957
)
Cavilla
JL
Kennedy
CR
Byskov
AG
Hartshorne
GM
Human immature oocytes grow during culture for IVM
Hum Reprod
 , 
2008
, vol. 
23
 (pg. 
37
-
45
)
Chian
RC
Buckett
WM
Abdul Jalil
AK
Son
WY
Sylvestre
C
Rao
D
Tan
SL
Natural-cycle in vitro fertilization combined with in vitro maturation of immature oocytes is a potential approach in infertility treatment
Fertil Steril
 , 
2004
, vol. 
82
 (pg. 
1675
-
1678
)
Combelles
CM
Cekleniak
NA
Racowsky
C
Albertini
DF
Assessment of nuclear and cytoplasmic maturation in in-vitro matured human oocytes
Hum Reprod
 , 
2002
, vol. 
17
 (pg. 
1006
-
1016
)
Cortvrindt
R
Smitz
J
Van Steirteghem
AC
In-vitro maturation, fertilization and embryo development of immature oocytes from early preantral follicles from prepuberal mice in a simplified culture system
Hum Reprod
 , 
1996
, vol. 
11
 (pg. 
2656
-
2666
)
Cvancarova
M
Samuelsen
SO
Magelssen
H
Fosså
SD
Reproduction rates after cancer treatment: experience from the Norwegian radium hospital
J Clin Oncol
 , 
2009
, vol. 
27
 (pg. 
334
-
343
)
Demeestere
I
Simon
P
Buxant
F
Robin
V
Fernandez
SA
Centner
J
Delbaere
A
Englert
Y
Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report
Hum Reprod
 , 
2006
, vol. 
21
 (pg. 
2010
-
2014
)
Demeestere
I
Simon
P
Emiliani
S
Delbaere
A
Englert
Y
Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease
Oncologist
 , 
2007
, vol. 
12
 (pg. 
1437
-
1442
)
Donnez
J
Dolmans
MM
Demylle
D
Jadoul
P
Pirard
C
Squifflet
J
Martinez-Madrid
B
van Langendonckt
A
Livebirth after orthotopic transplantation of cryopreserved ovarian tissue
Lancet
 , 
2004
, vol. 
364
 (pg. 
1405
-
1410
)
Eppig
JJ
O'Brien
MJ
Development in vitro of mouse oocytes from primordial follicles
Biol Reprod
 , 
1996
, vol. 
54
 (pg. 
197
-
207
)
Eppig
JJ
Schroeder
AC
Capacity of mouse oocytes from preantral follicles to undergo embryogenesis and development to live young after growth, maturation, and fertilization in vitro
Biol Reprod
 , 
1989
, vol. 
41
 (pg. 
268
-
276
)
Gosden
RG
Baird
DT
Wade
JC
Webb
R
Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196 degrees C
Hum Reprod
 , 
1994
, vol. 
9
 (pg. 
597
-
603
)
Gougeon
A
Regulation of ovarian follicular development in primates: facts and hypotheses
Endocr Rev
 , 
1996
, vol. 
17
 (pg. 
121
-
155
)
Groome
NP
Illingworth
PJ
O'Brien
M
Pai
R
Rodger
FE
Mather
JP
McNeilly
AS
Measurement of dimeric inhibin B throughout the human menstrual cycle
J Clin Endocrinol Metab
 , 
1996
, vol. 
81
 (pg. 
1401
-
1405
)
Gutierrez
CG
Ralph
JH
Telfer
EE
Wilmut
I
Webb
R
Growth and antrum formation of bovine preantral follicles in long-term culture in vitro
Biol Reprod
 , 
2000
, vol. 
62
 (pg. 
1322
-
1328
)
Hovatta
O
Silye
R
Abir
R
Krausz
T
Winston
RM
Extracellular matrix improves survival of both stored and fresh human primordial and primary ovarian follicles in long-term culture
Hum Reprod
 , 
1997
, vol. 
12
 (pg. 
1032
-
1036
)
Jeruss
JS
Woodruff
TK
Preservation of Fertility in Patients with Cancer
N Engl J Med
 , 
2009
, vol. 
360
 (pg. 
902
-
911
)
Juretzka
MM
O'Hanlan
KA
Katz
SL
El-Danasouri
I
Westphal
LM
Embryo cryopreservation after diagnosis of stage IIB endometrial cancer and subsequent pregnancy in a gestational carrier
Fertil Steril
 , 
2005
, vol. 
83
 pg. 
1041
 
Klein
NA
Houmard
BS
Hansen
KR
Woodruff
TK
Sluss
PM
Bremner
WJ
Soules
MR
Age-related analysis of inhibin A, inhibin B, and activin a relative to the intercycle monotropic follicle-stimulating hormone rise in normal ovulatory women
J Clin Endocrinol Metab
 , 
2004
, vol. 
89
 (pg. 
2977
-
2981
)
Kreeger
PK
Fernandes
NN
Woodruff
TK
Shea
LD
Regulation of mouse follicle development by follicle-stimulating hormone in a three-dimensional in vitro culture system is dependent on follicle stage and dose
Biol Reprod
 , 
2005
, vol. 
73
 (pg. 
942
-
950
)
Kreeger
PK
Deck
JW
Woodruff
TK
Shea
LD
The in vitro regulation of ovarian follicle development using alginate-extracellular matrix gels
Biomaterials
 , 
2006
, vol. 
27
 (pg. 
714
-
723
)
Lee
DM
Yeoman
RR
Battaglia
DE
Stouffer
RL
Zelinski-Wooten
MB
Fanton
JW
Wolf
DP
Live birth after ovarian tissue transplant
Nature
 , 
2004
, vol. 
428
 (pg. 
137
-
138
)
Lee
SJ
Schover
LR
Partridge
AH
Patrizio
P
Wallace
WH
Hagerty
K
Beck
LN
Brennan
LV
Oktay
K
American Society of Clinical Oncology recommendations on fertility preservation in cancer patients
J Clin Oncol
 , 
2006
, vol. 
24
 (pg. 
2917
-
2931
)
Meirow
D
Ben Yehuda
D
Prus
D
Poliack
A
Schenker
JG
Rachmilewitz
EA
Lewin
A
Ovarian tissue banking in patients with Hodgkin's disease: is it safe?
Fertil Steril
 , 
1998
, vol. 
69
 (pg. 
996
-
998
)
Meirow
D
Levron
J
Eldar-Geva
T
Hardan
I
Fridman
E
Zalel
Y
Schiff
E
Dor
J
Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy
N Engl J Med
 , 
2005
, vol. 
353
 (pg. 
318
-
321
)
Meirow
D
Hardan
I
Dor
J
Fridman
E
Elizur
S
Ra'anani
H
Slyusarevsky
E
Amariglio
N
Schiff
E
Rechavi
G
, et al.  . 
Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients
Hum Reprod
 , 
2008
, vol. 
23
 (pg. 
1007
-
1013
)
Newton
H
Picton
H
Gosden
RG
In vitro growth of oocyte-granulosa cell complexes isolated from cryopreserved ovine tissue
J Reprod Fertil
 , 
1999
, vol. 
115
 (pg. 
141
-
150
)
O'Brien
MJ
Pendola
JK
Eppig
JJ
A revised protocol for in vitro development of mouse oocytes from primordial follicles dramatically improves their developmental competence
Biol Reprod
 , 
2003
, vol. 
68
 (pg. 
1682
-
1686
)
Oktay
K
Buyuk
E
Davis
O
Yermakova
I
Veeck
L
Rosenwaks
Z
Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen
Hum Reprod
 , 
2003
, vol. 
18
 (pg. 
90
-
95
)
Oktay
K
Buyuk
E
Veeck
L
Zaninovic
N
Xu
K
Takeuchi
T
Opsahl
M
Rosenwaks
Z
Embryo development after heterotopic transplantation of cryopreserved ovarian tissue
Lancet
 , 
2004
, vol. 
363
 (pg. 
837
-
840
)
Oktay
K
Buyuk
E
Libertella
N
Akar
M
Rosenwaks
Z
Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation
J Clin Oncol
 , 
2005
, vol. 
23
 (pg. 
4347
-
4353
)
Picton
HM
Danfour
MA
Harris
SE
Chambers
EL
Huntriss
J
Growth and maturation of oocytes in vitro
Reprod Suppl
 , 
2003
, vol. 
61
 (pg. 
445
-
462
)
Porcu
E
Venturoli
S
Damiano
G
Ciotti
PM
Notarangelo
L
Paradisi
R
Moscarini
M
Ambrosini
G
Healthy twins delivered after oocyte cryopreservation and bilateral ovariectomy for ovarian cancer
Reprod Biomed Online
 , 
2008
, vol. 
17
 (pg. 
265
-
267
)
Rao
GD
Chian
RC
Son
WS
Gilbert
L
Tan
SL
Fertility preservation in women undergoing cancer treatment
Lancet
 , 
2004
, vol. 
363
 (pg. 
1829
-
1830
)
Rosendahl
M
Loft
A
Byskov
AG
Ziebe
S
Schmidt
KT
Andersen
AN
Ottosen
C
Andersen
CY
Biochemical pregnancy after fertilization of an oocyte aspirated from a heterotopic autotransplant of cryopreserved ovarian tissue: case report
Hum Reprod
 , 
2006
, vol. 
21
 (pg. 
2006
-
2009
)
Roy
SK
Treacy
BJ
Isolation and long-term culture of human preantral follicles
Fertil Steril
 , 
1993
, vol. 
59
 (pg. 
783
-
790
)
Salle
B
Demirci
B
Franck
M
Rudigoz
RC
Guerin
JF
Lornage
J
Normal pregnancies and live births after autograft of frozen-thawed hemi-ovaries into ewes
Fertil Steril
 , 
2002
, vol. 
77
 (pg. 
403
-
408
)
Schmidt
KL
Andersen
CY
Loft
A
Byskov
AG
Ernst
E
Andersen
AN
Follow-up of ovarian function post-chemotherapy following ovarian cryopreservation and transplantation
Hum Reprod
 , 
2005
, vol. 
20
 (pg. 
3539
-
3546
)
Schover
LR
Rates of postcancer parenthood
J Clin Oncol
 , 
2009
, vol. 
27
 (pg. 
321
-
322
)
Scott
JE
Carlsson
IB
Bavister
BD
Hovatta
O
Human ovarian tissue cultures: extracellular matrix composition, coating density and tissue dimensions
Reprod Biomed Online
 , 
2004
, vol. 
a 9
 (pg. 
287
-
293
)
Scott
JE
Zhang
P
Hovatta
O
Benefits of 8-bromo-guanosine 3′,5′-cyclic monophosphate (8-br-cGMP) in human ovarian cortical tissue culture
Reprod Biomed Online
 , 
2004
, vol. 
b 8
 (pg. 
319
-
324
)
Shaw
J
Trounson
A
Oncological implications in the replacement of ovarian tissue
Hum Reprod
 , 
1997
, vol. 
12
 (pg. 
403
-
405
)
Silber
SJ
Gosden
RG
Ovarian transplantation in a series of monozygotic twins discordant for ovarian failure
N Engl J Med
 , 
2007
, vol. 
356
 (pg. 
1382
-
1384
)
Silber
SJ
Lenahan
KM
Levine
DJ
Pineda
JA
Gorman
KS
Friez
MJ
Crawford
EC
Gosden
RG
Ovarian transplantation between monozygotic twins discordant for premature ovarian failure
N Engl J Med
 , 
2005
, vol. 
353
 (pg. 
58
-
63
)
Silber
SJ
Grudzinskas
G
Gosden
RG
Successful pregnancy after microsurgical transplantation of an intact ovary
N Engl J Med
 , 
2008
, vol. 
359
 (pg. 
2617
-
2618
)
Spears
N
Boland
NI
Murray
AA
Gosden
RG
Mouse oocytes derived from in vitro grown primary ovarian follicles are fertile
Hum Reprod
 , 
1994
, vol. 
9
 (pg. 
527
-
532
)
Telfer
EE
Binnie
JP
McCaffery
FH
Campbell
BK
In vitro development of oocytes from porcine and bovine primary follicles
Mol Cell Endocrinol
 , 
2000
, vol. 
163
 (pg. 
117
-
123
)
Telfer
EE
McLaughlin
M
Ding
C
Thong
KJ
A two-step serum-free culture system supports development of human oocytes from primordial follicles in the presence of activin
Hum Reprod
 , 
2008
, vol. 
23
 (pg. 
1151
-
1158
)
Thomas
FH
Campbell
BK
Armstrong
DG
Telfer
EE
Effects of IGF-I bioavailability on bovine preantral follicular development in vitro
Reproduction
 , 
2007
, vol. 
133
 (pg. 
1121
-
1128
)
Welt
CK
McNicholl
DJ
Taylor
AE
Hall
JE
Female reproductive aging is marked by decreased secretion of dimeric inhibin
J Clin Endocrinol Metab
 , 
1999
, vol. 
84
 (pg. 
105
-
111
)
West
ER
Xu
M
Woodruff
TK
Shea
LD
Physical properties of alginate hydrogels and their effects on in vitro follicle development
Biomaterials
 , 
2007
, vol. 
28
 (pg. 
4439
-
4448
)
West-Farrell
ER
Xu
M
Gomberg
MA
Chow
YH
Woodruff
TK
Shea
LD
The mouse follicle microenvironment regulates antrum formation and steroid production: alterations in gene expression profiles
Biol Reprod
 , 
2009
, vol. 
80
 (pg. 
432
-
439
)
Wright
CS
Hovatta
O
Margara
R
Trew
G
Winston
RM
Franks
S
Hardy
K
Effects of follicle-stimulating hormone and serum substitution on the in-vitro growth of human ovarian follicles
Hum Reprod
 , 
1999
, vol. 
14
 (pg. 
1555
-
1562
)
Wu
J
Emery
BR
Carrell
DT
In vitro growth, maturation, fertilization, and embryonic development of oocytes from porcine preantral follicles
Biol Reprod
 , 
2001
, vol. 
64
 (pg. 
375
-
381
)
Xu
M
Kreeger
PK
Shea
LD
Woodruff
TK
Tissue-engineered follicles produce live, fertile offspring
Tissue Eng
 , 
2006
, vol. 
a 12
 (pg. 
2739
-
2746
)
Xu
M
West
E
Shea
LD
Woodruff
TK
Identification of a stage-specific permissive in vitro culture environment for follicle growth and oocyte development
Biol Reprod
 , 
2006
, vol. 
b 75
 (pg. 
916
-
923
)
Xu
M
Woodruff
TK
Shea
LD
Bioengineering and the ovarian follicle
Cancer treatment and research
 , 
2007
, vol. 
138
 (pg. 
75
-
82
)
Xu
M
Banc
A
Woodruff
TK
Shea
LD
Secondary follicle growth and oocyte maturation by culture in alginate hydrogel following cryopreservation of the ovary or individual follicles
Biotechnol Bioeng
 , 
2009
Yang
D
Brown
SE
Nguyen
K
Reddy
V
Brubaker
C
Winslow
KL
Live birth after the transfer of human embryos developed from cryopreserved oocytes harvested before cancer treatment
Fertil Steril
 , 
2007
, vol. 
87
 (pg. 
1469e1
-
4
)